Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

NCT03808337

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +16 more
Locations
  • Natera, Inc. (Data and Specimen Analysis Only) San Carlos, California, United States
  • Hartford Healthcare Hartford, Connecticut, United States
  • WCHN Norwalk Hospital - Data Collection Norwalk, Connecticut, United States
  • Baptist Alliance - McI Miami, Florida, United States
View Trial Details
Recruiting

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment

NCT07281833

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +14 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • CHC MontLegia Liège, Belgium
  • St. Elisabeth-Krankenhaus GmbH, Brustzentrum - Senologie Cologne, North Rhine-Westphalia, Germany
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
View Trial Details
Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

NCT06099769

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Francisco (Data collection only) San Francisco, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Dana Farber Cancer Institute (Data Collection Only) Boston, Massachusetts, United States
View Trial Details
Recruiting

FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer

NCT06877949

Conditions
Breast Diseases, Breast Neoplasms, Disease Attributes, +9 more
Locations
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Esbjerg and Grindsted Hospital Esbjerg, Denmark
View Trial Details
Recruiting

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

NCT04683679

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

NCT06064812

Conditions
Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Huizhou First Hospital Huizhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
View all 22 locations
View Trial Details

Related conditions